IBDEI35J ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50329,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,50329,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,50329,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,50330,0)
 ;;=E27.3^^193^2490^4
 ;;^UTILITY(U,$J,358.3,50330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50330,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,50330,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,50330,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,50331,0)
 ;;=E29.1^^193^2490^35
 ;;^UTILITY(U,$J,358.3,50331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50331,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,50331,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,50331,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,50332,0)
 ;;=E55.9^^193^2490^42
 ;;^UTILITY(U,$J,358.3,50332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50332,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,50332,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,50332,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,50333,0)
 ;;=E66.01^^193^2490^20
 ;;^UTILITY(U,$J,358.3,50333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50333,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,50333,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,50333,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,50334,0)
 ;;=E66.8^^193^2490^24
 ;;^UTILITY(U,$J,358.3,50334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50334,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,50334,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,50334,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,50335,0)
 ;;=E66.9^^193^2490^25
 ;;^UTILITY(U,$J,358.3,50335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50335,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,50335,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,50335,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,50336,0)
 ;;=E74.39^^193^2490^16
 ;;^UTILITY(U,$J,358.3,50336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50336,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,50336,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,50336,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,50337,0)
 ;;=E83.30^^193^2490^28
 ;;^UTILITY(U,$J,358.3,50337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50337,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,50337,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,50337,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,50338,0)
 ;;=E83.51^^193^2490^9
 ;;^UTILITY(U,$J,358.3,50338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50338,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,50338,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,50338,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,50339,0)
 ;;=E83.52^^193^2490^7
 ;;^UTILITY(U,$J,358.3,50339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50339,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,50339,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,50339,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,50340,0)
 ;;=E87.5^^193^2490^8
 ;;^UTILITY(U,$J,358.3,50340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50340,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,50340,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,50340,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,50341,0)
 ;;=E89.2^^193^2490^30
 ;;^UTILITY(U,$J,358.3,50341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50341,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,50341,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,50341,2)
 ;;=^5003037
